Dyadic International Appoints Michael Tarnok as Chairman of the Board of Directors
operations and marketing. He is also the current Chairman and former Interim CEO of Keryx Biopharmaceuticals,
Inc.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.65 USD | -0.60% | +13.80% | +2.48% |
May. 14 | Transcript : Dyadic International, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Earnings Flash (DYAI) DYADIC INTERNATIONAL Posts Q1 Revenue $334.6M | MT |
1st Jan change | Capi. | |
---|---|---|
+2.48% | 48.24M | |
+33.63% | 50.93B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B |